RTW Venture Fund Ltd (RTW) - Cash Flow Conversion Efficiency
Based on the latest financial reports, RTW Venture Fund Ltd (RTW) has a cash flow conversion efficiency ratio of 0.052x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($30.70 Million) by net assets ($585.20 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RTW net asset quality score to measure how much of total assets are equity-financed.
RTW Venture Fund Ltd - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how RTW Venture Fund Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check RTW Venture Fund Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
RTW Venture Fund Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of RTW Venture Fund Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Global Infotech Co Ltd
SHE:300465
|
0.360x |
|
Crossamerica Partners LP
NYSE:CAPL
|
-0.355x |
|
GHT Co Ltd Class A
SHE:300711
|
0.058x |
|
NationGate Holdings Berhad
KLSE:0270
|
0.091x |
|
PROSEGUR CASH UNSP.ADR/5
F:PQD0
|
N/A |
|
Shenzhen Centralcon Investment Holding Co Ltd
SHE:000042
|
0.767x |
|
Vercom SA
WAR:VRC
|
0.066x |
|
Suzhou Delphi Laser Co. Ltd. A
SHG:688170
|
N/A |
Annual Cash Flow Conversion Efficiency for RTW Venture Fund Ltd (2017–2025)
The table below shows the annual cash flow conversion efficiency of RTW Venture Fund Ltd from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see RTW Venture Fund Ltd market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $865.22 Million | $105.25 Million | 0.122x | +161.90% |
| 2024-12-31 | $632.64 Million | $-124.34 Million | -0.197x | -351.39% |
| 2023-12-31 | $429.02 Million | $33.54 Million | 0.078x | +273.56% |
| 2022-12-31 | $347.92 Million | $-15.67 Million | -0.045x | +61.12% |
| 2021-12-31 | $387.36 Million | $-44.87 Million | -0.116x | -341.06% |
| 2020-12-31 | $412.61 Million | $-10.84 Million | -0.026x | +91.49% |
| 2019-12-31 | $214.39 Million | $-66.16 Million | -0.309x | -45702.90% |
| 2018-12-31 | $65.72 Million | $-44.28K | -0.001x | +99.78% |
| 2017-12-31 | $37.80 Million | $-11.71 Million | -0.310x | -- |
About RTW Venture Fund Ltd
RTW Biotech Opportunities Ltd is a venture capital fund. The fund specializes in directly investing and early-stage. The fund specializes in identifying transformative assets with high growth potential across the life sciences, biopharmaceutical and medical technology sectors. The fund invests in companies developing next-generation therapies and technologies that can significantly improve patien… Read more